BURLINGTON, N.C., May 13, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Pixel by Labcorp COVID-19 PCR Test Home Collection Kit for ages 2-17. The authorization expands the use of Pixel by Labcorp to children and adolescents 2 years of age and older when purchased by a parent or guardian.
BURLINGTON, N.C., June 30, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, today announced the extension of its work with the U.S. Centers for Disease Control and Prevention (CDC) to help identify and monitor variants of SARS-CoV-2, the virus that causes COVID-19.
Labcorp Adopts Molecular Loop SARS-CoV-2 Research Sequencing Panel for Large-Scale Viral Surveillance
Molecular Loop Biosciences, Inc. , a company redefining the simplicity of targeted sequencing, announced today that its SARS-CoV-2 Research Sequencing Panel has been deployed by Labcorp (NYSE: LH), a leading global life sciences company, to help sequence thousands of complete coronavirus genomes each week from positive patient samples. This sequencing is being performed as part of a U.S. Centers for Disease Control and Prevention (CDC) effort to identify and track the spread of SARS-CoV-2 variants throughout the country.
The North Carolina Department of Health and Human Services today announced the state is expanding availability of its at-home COVID-19 test collection. Any North Carolina resident may receive a Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit that is shipped overnight directly to their homes at no cost. Tests can be used on people age 2 and up.
BURLINGTON, N.C.--(BUSINESS WIRE)--May 24, 2021-- Nearly 87% of naturally infected COVID-19 patients maintained antibodies to SARS-CoV-2 proteins for at least 10 months, according to a new Labcorp (NYSE: LH) analysis of specimens from 39,086 individuals.
Labcorp and the U.S. Department of Health and Human Services Join Forces to Raise Awareness of COVID-19 Treatments
BURLINGTON, N.C., May 11, 2021 — Labcorp (NYSE: LH), a leading global life sciences company, is working with the U.S. Department of Health and Human Services (HHS) to raise awareness of potentially lifesaving monoclonal antibody COVID-19 therapies.
BURLINGTON, N.C. — Labcorp (NYSE: LH), a leading global life sciences company, today announced the availability of the Pixel by Labcorp® COVID-19 PCR Test Home Collection Kit for small businesses, an initiative aimed at providing fast, convenient, and reliable testing for companies with as many as 120 employees. Labcorp Employer Services currently provides COVID-19 testing and vaccination services for larger organizations and communities.
RALEIGH — While vaccine supplies are limited, it is important North Carolinians continue practicing the 3Ws and get tested for COVID-19 if they have symptoms or have been in close contact to someone with COVID-19.
Walgreens to Make Pixel by Labcorp™ COVID-19 PCR Test Home Collection Kit Available Over-The-Counter at Stores Nationwide
Kit to be available for purchase at Walgreens without a prescription and will allow for greater access to testing, helping reduce the spread of COVID-19 and improve the health of communities
Natick, Massachusetts Mass Vaccination Site | Opening Remarks | Bill Haas, senior vice president, Northeast Division, Labcorp
Thank you for joining us today at our mass vaccination site here at the Natick Mall. I’m Bill Haas, senior vice president of the northeast division at Labcorp. We’re thrilled to be working across the commonwealth to make it easier for people to get tested and vaccinated, as we all work together to slow the spread of COVID-19.
Pacific Biosciences Sequel II Systems Deployed to Scale-Up Global Viral Surveillance Initiatives Focused on COVID-19
Labcorp Using PacBio’s HiFi Sequencing to Detect SARS-CoV-2 Variants in the U.S.
Antigen Test Is the Latest Offering by Labcorp to Fight COVID-19 at Every Stage, from Diagnostic Testing to Clinical Trials and Vaccination Services
Labcorp's COVID-19 PCR Testing
Average Time to Result from Specimen Pickup
Molecular tests performed
Molecular test capacity per day**
Antibody tests performed
Antibody test capacity per day**
Tests Offered with No Upfront Costs*
Stats updated as of July 31, 2021. COVID-19 volumes are U.S. only. Future COVID-19 test volumes will be updated quarterly after the release of Labcorp’s quarterly earnings results.
*A $6 non-refundable physician fee is charged for the IgG antibody test if it is requested through Labcorp.com
**Capacity numbers are subject to sufficient equipment and supplies
Tracking COVID-19 Variants
We have been regularly tracking variants of the virus throughout the pandemic. The sensitivity of our PCR test is not impacted by these variants.
Labcorp PCR Test Performance Confirmed
Alpha (B.1.1.7, Q.1-Q.8)
Beta (B.1.351, B.1.351.2, B.1.351.3)
Epsilon (B.1.427, B.1.429)
Gamma (P.1, P.1.1, P.1.2)
Labcorp has been working with the Centers for Disease Control and Prevention (CDC) to provide sequencing of samples of SARS-CoV-2, the virus that causes COVID-19.
For more information visit US COVID-19 Cases Caused by Variants on the CDC website.
Data covers the U.S. including the District of Columbia and Puerto Rico.
Total number of samples sequenced: 70,000 (as of July 2, 2021)